Indications
Therapeutic Asset Ratings
6,305 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pidnarulex
Large B-Cell Lymphoma
National Cancer Institute (NCI)
P1/2
CC
(47)
plb1004
Lung Cancer
Beijing Pearl Biotechnology Limited Liability Company
P1/2
CC
(47)
Plerixafor
Beta Thalassemia
National Heart, Lung, and Blood Institute (NHLBI)
P1/2
CC
(47)
Plerixafor
Follicular Lymphoma
Case Comprehensive Cancer Center
P1/2
CC
(47)
Plerixafor
Mantle Cell Lymphoma
Case Comprehensive Cancer Center
P1/2
CC
(47)
Pocenbrodib
Castration-Resistant Prostate Carcinoma
Pathos AI, Inc.
P1/2
CC
(47)
Polatuzumab Vedotin
Post-Transplant Lymphoproliferative Disease
Washington University School of Medicine
P1/2
CC
(47)
Polo-Like Kinase 1 Inhibitor Nms-1286937
Invasive Breast Carcinoma
Antonio Giordano, MD
P1/2
CC
(47)
Polyethyleneglycol-7-Ethyl-10-Hydroxycamptothecin Dfp-13318
Medulloblastoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Pomalidomide
Corneal Disorder
Hellenic Society of Hematology
P1/2
CC
(47)
Pomalidomide
Monoclonal Gammopathy
Hellenic Society of Hematology
P1/2
CC
(47)
Pomalidomide
Hematopoietic And Lymphoid System Neoplasm
CellCentric Ltd.
P1/2
CC
(47)
Posaconazole
Adult Acute Lymphoblastic Leukemia
AstraZeneca
P1/2
CC
(47)
Posaconazole
Myelodysplastic/Myeloproliferative Neoplasm
BeiGene
P1/2
CC
(47)
Poseltinib
Large B-Cell Lymphoma
Seoul National University Hospital
P1/2
CC
(47)
Prednisone
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Shanghai Jiao Tong University School of Medicine
P1/2
CC
(47)
Prednisone
Frontotemporal Dementia
Prevail Therapeutics
P1/2
CC
(47)
Prior-Hsct Donor-Derived Cd7 Car T-Cell
T-Cell And NK-Cell Neoplasm
Beijing GoBroad Hospital
P1/2
CC
(47)
Prizloncabtagene Autoleucel
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Shanghai AbelZeta Ltd.
P1/2
CC
(47)
Psma/13
B-Cell Non-Hodgkin Lymphoma
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(47)
Pumitamig
Triple-Negative Breast Carcinoma
Bristol-Myers Squibb
P1/2
CC
(47)
q702
Hepatocellular Carcinoma
Qurient Co., Ltd.
P1/2
CC
(47)
Quaratusugene Ozeplasmid
Small Cell Lung Carcinoma
Genprex, Inc.
P1/2
CC
(47)
Quemliclustat
Bladder Transitional Cell Carcinoma
Fred Hutchinson Cancer Center
P1/2
CC
(47)
Quemliclustat
Renal Pelvis Urothelial Carcinoma
Fred Hutchinson Cancer Center
P1/2
CC
(47)
Showing 2551 to 2575 of 6,305 assets
Previous
Page 103 of 253
Next